Blocking JAK1 Signaling Slows AML Growth (IMAGE)
Caption
Blocking JAK1 signaling slowed the growth of acute myeloid leukemia (AML) cancer cells with the CALM-AF10 subtype (right)--compared to cancer cells that had JAK1 signaling (left). These findings indicate that existing JAK1 inhibitors may be a promising treatment option for this cancer.
Credit
Sanford Burnham Prebys
Usage Restrictions
None
License
Licensed content